Skip to Content

Powerful new obesity drug poised to upend weight loss care


AP Health Writer

A diabetes drug being tested for weight loss is poised to further upend obesity care. Drugmaker Eli Lilly reported Thursday that tirzepatide helped people with diabetes who were overweight or had obesity lose up to 16% of their body weight over 17 months in a late-stage trial. For those without the disease, the drug has prompted losses of more than 20% of body weight. Known as Mounjaro for diabetes use, the drug has been used “off label” for weight loss since last year. Lilly is applying for fast-track approval from U.S. regulators. Analysts have predicted tirzepatide could become one of the top-selling drugs ever, with annual sales topping $50 billion.

Article Topic Follows: AP National

Jump to comments ↓

Author Profile Photo

Associated Press


KIFI Local News 8 is committed to providing a forum for civil and constructive conversation.

Please keep your comments respectful and relevant. You can review our Community Guidelines by clicking here

If you would like to share a story idea, please submit it here.

Skip to content